Division of Translational Cancer Research
271 – 280 of 599
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Integrative discovery of treatments for high-risk neuroblastoma
(
- Contribution to journal › Article
-
Mark
Evolution of estrogen receptor status from primary tumors to metastasis and serially collected circulating tumor cells
(
- Contribution to journal › Article
-
Mark
Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression
(
- Contribution to journal › Article
-
Mark
Loss of PI3 kinase association improves the sensitivity of secondary mutation of KIT to Imatinib
(
- Contribution to journal › Article
-
Mark
Hypoxia-induced release, nuclear translocation, and signaling activity of a DLK1 intracellular fragment in glioma
2020) In Oncogene(
- Contribution to journal › Article
-
Mark
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
(
- Contribution to journal › Article
- 2019
-
Mark
Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease
(
- Contribution to journal › Article
-
Mark
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
(
- Contribution to journal › Article
-
Mark
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
(
- Contribution to journal › Article
-
Mark
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
(
- Contribution to journal › Article